How Incretin-Based Therapies Work in Weight Management

How GLP-1 Receptor Agonists and Dual GLP-1/GIP Receptor Agonists Work for Weight Management

Incretin-based therapies, including GLP-1 receptor agonists and dual GLP-1/GIP receptor agonists, are relatively new medications used for supporting weight management in eligible people. These treatments mimic natural gut hormones, addressing biological factors that make weight loss challenging, such as appetite regulation and metabolism. Used as an adjunct to lifestyle changes, they can help achieve meaningful reductions in body weight, while improving related health conditions like type 2 diabetes and cardiovascular risks.

This guide explains how they work, based on clinical evidence, and whether they may be suitable in your case.

What Are Incretin Hormones and Why Do They Matter?

Incretins are hormones released by the gut in response to food intake, playing a role in regulating blood sugar, appetite, and digestion. GLP-1 (glucagon-like peptide-1) is secreted by cells in the lower part of the small intestine, while GIP (glucose-dependent insulinotropic polypeptide) comes from cells in the upper small intestine. These hormones influence multiple body systems, including the brain, pancreas, stomach, and adipose (fat) tissue, to help maintain energy balance.

In obesity, these pathways can become poorly regulated in the body, leading to increased hunger and reduced sense of fullness after eating. Incretin-based therapies target these systems to restore balance, which can make them effective for weight management when lifestyle alone is not achieving enough.

Mechanism of GLP-1 Receptor Agonists

GLP-1 receptor agonists activate receptors in key areas like the pancreas, stomach, brain , kidney, heart, and adipose (fat) tissue. Their main actions include:

Appetite Suppression: By acting on the brain, they reduce food cravings, lower overall caloric intake, and enhance feelings of fullness.
Improved Insulin Dynamics: They boost glucose-dependent insulin secretion from the pancreas while reducing glucagon release, helping stabilize blood sugar.
Delayed Gastric Emptying: This slows digestion, prolonging satiety after meals.

These effects collectively can support weight reduction (typically 10-15% in scientific trials) and offer additional benefits such as better glucose control and reduced cardiovascular risk. They are administered via weekly subcutaneous injection, with gradual increase in dose to minimise the chance of side effects.

Mechanism of Dual GLP-1/GIP Receptor Agonists

Dual agonists target both GLP-1 and GIP receptors. GIP adds complementary effects:

Stronger Insulin Response: GIP has a more pronounced impact on insulin release after oral glucose intake, aiding blood sugar management.
Adipose Tissue Support: It increases insulin sensitivity in fat tissue, improves blood flow, and reduces free fatty acid release—helping with fat metabolism without directly suppressing appetite or slowing gastric emptying like GLP-1.

This dual approach often leads to better outcomes (e.g., 15-20% weight reduction in studies) compared to single GLP-1 agonists, with similar injection-based administration and gradual dose titration.

Benefits Beyond Weight Loss

These therapies not only aid weight management but also show promise in areas like heart failure, metabolic-associated fatty liver disease, knee osteoarthritis, obstructive sleep apnoea, and cardiovascular risk. Interestingly, ongoing research is also looking at applications in neurodegenerative disorders, atrial fibrillation, and addiction.

Quick Checklist: Is This Approach Right for You?

Do you have obesity (BMI ≥30) or overweight (BMI ≥27) with related complications?
Are you committed to lifestyle changes as the foundation?

If so, weight loss medication may be suitable for you.

Key Takeaway

GLP-1 receptor agonists and dual GLP-1/GIP receptor agonists work by mimicking gut hormones to suppress appetite, improve insulin function, and support metabolic health—offering evidence-based adjuncts for weight management. Consult a doctor for personalised advice.

Ready to explore? Book a telehealth consultation at Doctors for Weight Loss by Qoctor, from $59.99.

Data last reviewed: January 27, 2026.